Fernando Gómez

Statistics

Publications

Citations

3.8K

H-Index

Active since

2003

Affiliations

Estudios Clínicos Latinoamérica(Current)

Universidad de La Frontera

Oregon Health & Science University

Population Health Research Institute

Hamilton Health Sciences

Fernando Gómez is an author at Estudios Clínicos Latinoamérica specializing in medicine, diabetes pharmacotherapy, and placebo-controlled efficacy assessment.

Publications per year

2003–2021

Publications

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

COVID-19 in children: Pathogenesis and current status

Lawrence D. Frenkel, Fernando Gómez, Joseph A. Bellanti · Allergy and Asthma Proceedings · 2021 · 46 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +13

A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease

Richard S. Castaldo, Bartolomé R. Celli, Fernando Gómez et al. · Clinical Therapeutics · 2003 · 31 citations

Pharmacy, Internal Medicine, Pharmacotherapy +13

Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus

Juan Pablo Arab, Juan Carlos Claro, Juan Pablo Arancibia et al. · World Journal of Hepatology · 2016 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

1–5 of 5